BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Edurant (Rilpivirine) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Edurant (Rilpivirine)\, from ClinicalTria
 ls.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07637877-958@assetmemo.bio
DTSTAMP:20261121T004950Z
DTSTART;VALUE=DATE:20281230
DTEND;VALUE=DATE:20281231
SUMMARY:Edurant (Rilpivirine): Phase 2 readout est. (NCT07637877)
DESCRIPTION:Edurant (Rilpivirine)\, phase 2\, HIV.\nStudy: Targeted Therapi
 es for Immunological Non-Responders in People With HIV: A Multicenter Clin
 ical Study\nEstimated primary completion: 30 December 2028. This is a Clin
 icalTrials.gov estimate\, not a confirmed readout date\, and it can move.\
 nDrug page: https://assetmemo.bio/drug/rilpivirine#upcoming-events\nRegist
 ry record: https://clinicaltrials.gov/study/NCT07637877
URL:https://assetmemo.bio/drug/rilpivirine#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
